Renal angiomyolipoma (AML) harboring a missense mutation of <i>TSC2</i> with copy-neutral loss of heterozygosity (CN-LOH)
-
- Masashi Idogawa
- Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Tokimasa Hida
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Toshiaki Tanaka
- Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Noriaki Ohira
- Keiwakai Nishioka Hospital, Sapporo, Japan
-
- Shoichiro Tange
- Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Yasushi Sasaki
- Biology, Department of Liberal Arts and Sciences Center for Medical Education, Sapporo Medical University, Sapporo, Japan
-
- Hisashi Uhara
- Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Naoya Masumori
- Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Takashi Tokino
- Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
-
- Hiroshi Natori
- Keiwakai Nishioka Hospital, Sapporo, Japan
Journal
-
- Cancer Biology & Therapy
-
Cancer Biology & Therapy 21 (4), 315-319, 2019-12-17
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1361694369053910016
-
- ISSN
- 15558576
- 15384047
-
- Data Source
-
- Crossref
- KAKEN